ArticleMedical hypotheses2022

A one-step platform for screening high-efficient and minimal off-target CRISPR/Cas13 crRNAs to eradicate SARS-CoV-2 virus for treatment of COVID-19 patients.

Pu-Yu Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.